{"SPADE_N_00135": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_00135", "Peptide Name": "Thuricin CDdbeta (Trn-beta; one peptide of Thuricin CD; Bacteriocin)", "Source": "Bacillus thuringiensis DPC 6431 (Gram-positive bacteria)", "Family": "Belongs to the class IIb bacteriocin", "Gene": "Not found", "Sequence": "GWVACVGACGTVCLASGGVGTEFAAASYFL", "Sequence Length": 30, "UniProt Entry": ["http://www.uniprot.org/uniprot/F5AT06"], "Protein Existence": "Predicted", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+"], "Target Organism": "Gram-positive bacteria:Clinical Clostridium difficile isolates (MIC in the range of nM) and Listeria monocytogenes, Lactobacillus fermentum.", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Trn-β was also found to be the LLD isomer, with L-stereochemistry at Thr21 (alpha-R), L-stereochemistry at Ala25 (alpha-R), and D-stereochemistry at Tyr28 (alpha-S).", "Formula": "C128H191N31O38S3", "Mass": 2868.27, "PI": 4.05, "Net Charge": -1, "Hydrophobicity": 1.24, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Function": "Thuricin CD is produced by Bacillus thuringiensis DPC 6431, a bacterial strain isolated from a human fecal sample, and it consists of two distinct peptides, Trn-alpha and Trn-beta, that act synergistically to kill a wide range of clinical C. difficile isolates. Thuricin CD showes no activity against any Gram-negative organisms tested, including Escherichia coli, Pseudomonas sp., Salmonella sp., and Bacteroides fragilis.", "Biophysicochemical properties": "Cell-free supernatants of thuricin were active throughout the pH range of 2-9 and heat stable up to 85 °C. There was, however, a reduction in activity at 90 °C and a complete loss of activity at 100 °C after 15 min.", "Literature": [{"Title": "Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.", "Pubmed ID": "20435915", "Reference": "Proc Natl Acad Sci U S A. 2010 May 18;107(20)9352-9357.", "Author": "Rea MC, Sit CS, Clayton E, O'Connor PM, Whittal RM, Zheng J, Vederas JC, Ross RP, Hill C.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=20435915"}, {"Title": "The 3D structure of thuricin CD, a two-component bacteriocin with cysteine sulfur to alpha-carbon cross-links.", "Pubmed ID": "21526839", "Reference": "J Am Chem Soc. 2011 May 25;133(20)7680-7683.", "Author": "Sit CS, McKay RT, Hill C, Ross RP, Vederas JC.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21526839"}], "Frequent Amino Acids": "AGV", "Absent Amino Acids": "DHIKMNOPQRU", "Basic Residues": 0, "Acidic Residues": 1, "Hydrophobic Residues": 16, "Polar Residues": 18, "Positive Residues": 0, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06155", "Similarity": 1.0, "Sequence": "MEVLNKQNVNIIPESEEVGGWVACVGACGTVCLASGGVGTEFAAASYFL"}, {"SPADE_ID": "SPADE_UN_11363", "Similarity": 0.8823529411764706, "Sequence": "GWVAVGAGTAALASGGV"}]}}}